
    
      PD-1 works to help tumor cells continue to grow and multiply. Pembrolizumab (MK-3475) is a
      humanized monoclonal antibody. Humanized monoclonal is an antibody that is designed to block
      the action of the receptor, PD-1.

      The FDA (the U.S. Food and Drug Administration) has not approved Pembrolizumab for
      Glioblastoma but it has been approved for other uses.
    
  